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ORIGINAL ARTICLEWhole genome sequencing for deciphering the resistome of
Chryseobacterium indologenes, an emerging multidrug-resistant bacterium
isolated from a cystic ﬁbrosis patient in Marseille, FranceT. Cimmino and J.-M. Rolain
Aix-Marseille Université, URMITE UM 63 CNRS 7278 IRD 198 INSERM U1905, IHU Méditerranée Infection, Facultés de Médecine et de Pharmacie,
Marseille, FranceAbstractWe decipher the resistome of Chryseobacterium indologenes MARS15, an emerging multidrug-resistant clinical strain, using the whole genome
sequencing strategy. The bacterium was isolated from the sputum of a hospitalized patient with cystic ﬁbrosis in the Timone Hospital in
Marseille, France. Genome sequencing was done with Illumina MiSeq using a paired-end strategy. The in silico analysis was done by RAST,
the resistome by the ARG-ANNOT database and detection of polyketide synthase (PKS) by ANTISMAH. The genome size of
C. indologenes MARS15 is 4 972 580 bp with 36.4% GC content. This multidrug-resistant bacterium was resistant to all β-lactams,
including imipenem, and also to colistin. The resistome of C. indologenes MARS15 includes Ambler class A and B β-lactams encoding
blaCIA and blaIND-2 genes and MBL (metallo-β-lactamase) genes, the CAT (chloramphenicol acetyltransferase) gene and the multidrug
efﬂux pump AcrB. Speciﬁc features include the presence of an urease operon, an intact prophage and a carotenoid biosynthesis pathway.
Interestingly, we report for the ﬁrst time in C. indologenes a PKS cluster that might be responsible for secondary metabolite biosynthesis,
similar to erythromycin. The whole genome sequence analysis provides insight into the resistome and the discovery of new details, such
as the PKS cluster.
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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E-mail: jean-marc.rolain@univ-amu.frIntroductionThe genus Chryseobacterium (family Flavobacteriaceae, phylum
Bacteroidetes) [1] is a group of Gram-negative, nonfermenting,
catalase-positive, oxidase-positive and indole-positive aerobic
bacilli [2]. Chryseobacterium strains have been isolated from a© 2016 The Authors. Published by El
This is an open access artivariety of environments, including composted diseased ﬁsh, soil
and plant rhizospheres [3].
C. indologenes is not normally present in the human micro-
ﬂora, although it is widely distributed in nature [4]. Chrys-
eobacterium indologenes can be found in water systems despite
chlorine treatment and on the wet surface of sink basins, taps,
medical tools and other equipment [5], creating a potential
reservoir for infection in hospital environments.
These primarily opportunistic pathogens infect mainly new-
borns [6] and patients with respiratory disease or immuno-
suppression [2]; patients with long-term indwelling devices may
become colonized with this bacterium after contact with
contaminated medical devices such as feeding tubes, intravas-
cular catheters and endotracheal tubes [4].New Microbe and New Infect 2016; 12: 35–42
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sentinel hospitals and laboratories in North America, Latin
America, Europe and the Asia-Paciﬁc region in the initial 5 years
of the program (1997 to 2001), revealed that Chryseobacterium
species constitute only 0.03% of all bacterial isolates. All strains
came from hospitalized patients. C. meningosepticum was the
most frequently isolated microorganism, followed by C. indolo-
genes. The lower respiratory tract (52%) and blood (46%) were
the major sites where the microorganism was isolated [5].
The ﬁrst clinical sample of C. indologenes was isolated in 1993
from the tracheal aspirate of a patient with ventilator-
associated pneumonia [7].
C. indologenes can cause various types of infections [2],
including keratitis, bacteraemia [2], pneumonia, cellulitis and
artiﬁcial shunt infection in Taiwan [8–11], Australia [12],
Europe [13–15] and the United States [16].
There is no reference standard or guideline for the thera-
peutic management of C. indologenes infection despite increasing
evidence of nosocomial-associated infections. An increased
resistance rate to previously potent antibiotics suggests that a
resistant pattern of C. indologenes may evolve over time and may
vary according to different trends in antibiotic usage [17].
This bacterium is multiresistant to several antimicrobial
drugs, particularly colistin, which is widely used for treatment
of P. aeruginosa colonization in patients with cystic ﬁbrosis (CF)
[18], while it is usually susceptible to trimethoprim–sulfa-
methoxazole and piperacillin–tazobactam.
The goal of this study was to decipher the resistome and
genome properties of clinical bacteria in the lung of CF patients
using whole genome sequencing (WGS).Materials and MethodsGrowth condition and identiﬁcation
C. indologenes was isolated on Cepacia medium (Becton Dick-
inson (BD), San Diego, CA, USA) from the sputum sample of a
15 years old CF girl regularly treated with aerosolized colistin
for chronic Pseudomonas aeruginosa exacerbations.
Presumptive identiﬁcation was done by matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS; Microﬂex, Bruker Daltonics, Leipzig, Ger-
many) using the ﬂex control software (Bruker Daltonics) as
previously described [19]. Growth was also tested using
different media, including trypticase soy agar (TSA) (bio-
Mérieux, Marcy-l’Étoile, France), Columbia agar with 5%
sheep’s blood (bioMérieux), selective chromogenic medium for
the screening of extended-spectrum β-lactamase (ESBL)-pro-
ducing Enterobacteriaceae (bioMérieux) and different salt
concentrations (2.5%, 5%, 7.5%, 10%, 15%). Electron© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licemicroscopy was performed on a TechnaiG2 Cryo (FEI Com-
pany, Limeil-Brevannes, France) at an operating voltage of 200
keV. The biochemical test was performed by API20NE
(bioMérieux).
Antibiotic susceptibility testing
Antibiotic susceptibility testing was done using the disk diffusion
method on Mueller-Hinton agar medium (bioMérieux). The
results were interpreted using the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) guidelines [20],
and minimum inhibitory concentrations (MICs) were deter-
mined by the Etest method (bioMérieux). Screening for met-
allo-β-lactamase activity was performed using modiﬁed Carba
NP (MCNP) [21].
Genome sequencing
Genome sequencing of C. indologenes MARS15 was done by
Illumina MiSeq (Illumina, San Diego, CA, USA) using the paired-
end strategy and producing 2 × 250 bp (average read length).
The assembly was performed using the SPAdes assembler, using
different K values equal to 21, 33, 55, 77, 99 and 127, auto-
matically chosen for this length read.
Genome annotation
The annotation was performed by Rapid Annotation using the
Subsytem Technology (RAST) bioserver [22]. Gene Ontology
(GO) in terms of Biological Process and Molecular Functions
and the Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways were considered. Detection of plasmid was per-
formed by PlasmidFinder [23]. The Antibiotic Resistance Gene
ANNotation (ARG-ANNOT database) was used to improve
the annotation of the antibiotic resistance gene [24]. The
intergenomic distances between genome sequences were
determined from fully or partially sequenced genomes using
average nucleotide identity and the percentage of conserved
DNA (minimum identity, 70%) [25]. The genome of
C. indologenes MARS15 was compared to the complete genome
of Chryseobacterium sp. stRB126 (accession no. NZ_AP014624)
and to the related genomes C. indologenes NBRC 14944
(accession no. NZ_BAVL00000000.1) and C. indologenes J31
(accession no. NZ_LAZY00000000.1). The Mauve alignment
tool (version 2.3.1) was used for multiple genomic sequence
alignment. RNAs were found by using RNAmmer [26]. PHAST
(PHAge search Tool) was used to identify phage sequences
[27]. The exhaustive bacteriocin database available in our lab-
oratories (Bacteriocins from the URMITE database; http://
drissifatima.wix.com/bacteriocins) was performed by collect-
ing all currently available sequences from the databases and
from the National Center for Biotechnology Information.
Protein sequences from this database allowed putativeiology and Infectious Diseases, NMNI, 12, 35–42
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the BLASTp methodology [28].
Analyses for the presence of polyketide synthase (PKS) and
nonribosomal peptide synthase (NRPS) were performed,
discriminating the gene with large size using a database realized
in our laboratory; predicted proteins were compared against
the nonredundant (nr) GenBank database using BLASTp and
analysed using the ANTibiotics and Secondary Metabolite
Analysis Shell [29].ResultsPhenotypic properties
C. indologenes MARS15 (http://www.mediterranee-infection.com/
arkotheque/client/ihumed/_depot_arko/articles/658/catalogue-
csur-27-10-2015_doc.pdf) was isolated in March 2013 from the
sputum sample of a 15-year-old girl with CF on Cepacia medium.
The isolate appearance had a pigmented pale yellow colour
(Fig. 1(A)). After 24 hours, the colonies were correctly identiﬁed
by MALDI-TOF MS as C. indologenes, with a good score (>2.0).
The isolate was able to grow on different culture media such as
TSA and COS media but did not grow on ESBL medium.
Moreover, the growth exhibited a high tolerance for sodium
chloride at concentrations up to 5% after 32 hours of incubation.
C. indologenes MARS15 is a Gram-negative, motile (via gliding)
bacillus bacterium. The motility test was positive, and electron
microscopy revealed the presence of a uniform distribution of
peritrichous ﬂagella around the cell wall (Fig. 1(B)). Phenotypi-
cally, C. indologenes MARS15 was resistant to amoxicillin (MIC
>256 μg/mL), amoxicillin–clavulanic acid, ticarcillin–clavulanic
acid, second-generation (cefoxitin) and third-generation cepha-
losporins (ceftazidime (MIC >6 μg/mL), ceftriaxone, imipenemFIG. 1. (A) Chryseobacterium indolo-
genes MARS15 isolated on Mueller-
Hinton agar. (B) Electron micro-
scopic image of C. indologenes
MARS15 using TechnaiG2 Cryo at
operating voltage of 200 keV.
© 2016 The Authors. Published by Elsevier Ltd on behal
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colistin (MIC >256 μg/mL), erythromycin (>4 μg/mL) and
chloramphenicol, but was susceptible to gentamicin, amikacin,
ciproﬂoxacin, trimethoprim–sulfamethoxazole and rifampicin
(Fig. 2(A)). The modiﬁed Carba NP test method for
carbapenemase-producing detection was positive (Fig. 2(B)).
Genome features
The genome size of C. indologenes MARS15 was 4 972 580 bp
with 36.4% GC content and assembled into 381 scaffolds. No
plasmid was detected. A total of 4592 open reading frames
(ORFs) were predicted, including 1754 (38%) ORFs annotated
as hypothetical proteins and 69 RNAs (one 23S rRNA, one 16S
rRNA and four 5S rRNA). Of the 4592 ORFs, 3072 were
assigned a putative function (by the Clusters of Orthologous
Groups (COGs) database), and 260 genes were identiﬁed with
an unknown function. Moreover, it contained a complete
prophage 57 kb in size and 35.5% GC content (Table 1).
Comparative analysis of genomes of C. indologenes MARS15
reveals more similarity of genome size, GC content, average
nucleotide identity (Table 1) and percentage protein sequence
identity (Fig. 3) between the clinical strain C. indologenes
MARS15 and the reference strain NBRC 14944.
Resistome
The resistome of this multidrug-resistant C. indologenes
MARS15 includes antibiotic resistant genes of the Ambler class
A β-lactamase encoding blaCIA and of the Ambler class B
β-lactamase blaIND-2, respectively, β-lactamase genes.
The blaCIA gene showed 99% identity with C. indologenes strain
NBRC 14944, while the blaIND-2 gene, already reported in
Chryseobacterium spp., shared 100% identity with C. indologenes
strain NBRC 14944. Moreover, C. indologenesMARS15 possessesf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 12, 35–42
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
FIG. 2. From genotype to phenotype of Chryseobacterium indologenes MARS15. (A) Antibiotic sensitivity testing. AK, amikacin; AMC, amoxicillin–
clavulanate acid; ATM, aztreonam; AX, amoxicillin; CIP, ciproﬂoxacin; CN, gentamicin; CRO, ceftriaxone; CT, colistin; CTX, cefotaxime; ETP,
ertapenem; FOX, cefoxitin; IPM, imipenem; SXT, trimethoprim–sulfamethoxazole; TIC, ticarcillin; TIM, ticarcillin–clavulanate acid; TOB, tobramycin.
(B) Results of modiﬁed Carba NP test; colour change of sample revealed presence of lactamases. (C) List of antibiotic-resistant genes. (D) Circular map
of chromosome. From outside to center: genes on forward and reverse strand rRNA and tRNA (green), GC content and GC skew.
38 New Microbes and New Infections, Volume 12 Number C, July 2016 NMNIfour MBL (metallo-β-lactamase) metallohydrolases with un-
known activity (Fig. 2(C)). Furthermore, we found a chloram-
phenicol acetyltransferase encoding CAT, monooxygenase
responsible for tetracycline resistance and the multidrug efﬂux
pump AcrB, known to be involved in drug resistance (Fig. 2(C)).TABLE 1. Genome features of Chryseobacterium indologenes MAR
Chryseobacterium sp. stRB126
Species Accession No. Genome size (Mb
C. indologenes MARS15 FCNN01000001-FCNN01000381 4.9
C. indologenes NBRC 14944 NZ_BAVL00000000 4.75
C. indologenes J31 NZ_LAZY00000000 5.83
Chryseobacterium sp. stRB126 NZ_AP014624 5.5
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
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Carotenoid biosynthesis. C. indologenes MARS15 has a character-
istic yellowish pigmentation on agar plates, caused by the pro-
duction of carotenoids, as reported for other Chryseobacterium
species.S15 genome compared to C. indologenes NBRC 14944 and
) GC% No. genes Average nucleotide identity Source
37.4 4592 — Pneumonia
37.2 4285 99.23 Pulmonary system
36.9 5422 82.72 Urine
35.6 4961 82.57% Potato
iology and Infectious Diseases, NMNI, 12, 35–42
nses/by-nc-nd/4.0/).
FIG. 3. Proteomic comparison and in silico DNA-DNA hybridization between MARS15 strain and most closely related species. (A) Colour code
referring to percentage of similarity of protein sequence. It refers to average of number of proteins with similarity 80% with Chryseobacterium
indologenes MARS15 proteome. (B.1) Graphic representation of proteomic comparison between C. indologenes J31 and (B.2) C. indologenes NBRC
14944 and (B.3) Chryseobacterium spp. (C) Representation of prophage absence in other Chryseobacterium analysed.
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cluster, including the crtY, crtZ, crtB, crtl and crtX encoding genes,
is responsible for the production of the yellow pigment. We
found the same arrangement between C. indologenes MARS15
and NBRC 14944, similar in Chryseobacterium strain RB126, but
the carotenoid biosynthesis enzyme is absent in C. indologenes
J31.
Urease operon. The C. indologenes MARS15 urease gene cluster
was composed of seven contiguous genes in a cluster of
4980 bp with 41.4% GC content. The structural genes, ureABC,
which encode subunits of the enzyme are ﬂanked immediately
upstream by ureD and downstream by the ureEFG encoded
urease accessory genes. Overall, hypothetical proteins had no
BLAST hits ﬂanking this cluster. The same arrangement is found
in C. indologenes strain NBRC 14944 and Chryseobacterium strain© 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access articRB126. A phylogenetic tree analysis of the concatenated urease
gene operons revealed that the urease operon in C. indologenes
MARS15 is related to that of Chryseobacterium spp. and Eliz-
abethkingia spp. (data not show).
Phage. In C. indologenes MARS15 we found an intact prophage of
57 kb and 35.5% GC content, whereas incomplete and ques-
tionable phages are found, respectively, in C. indologenes strain
NBRC 14944 and Chryseobacterium strain RB126; no phages
were found in the genome of C. indologenes strain J31
(Fig. 3(C)).
Secondary metabolite biosynthesis. The screening for PKS (Fig. 4)
and NRPS revealed one PKS and one cluster of NRPS. The
modular PKS, classiﬁed as type I, revealed that this cluster en-
codes erythronolide synthase and β-ketoacyl synthase. Thef of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 12, 35–42
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
40 New Microbes and New Infections, Volume 12 Number C, July 2016 NMNItotal size of PKS is 11.2 kb, with 43.7 GC%, and a similarity of
37% is found with the Saccharopolyspora erythraea bacterium,
already known to be erythromycin producing. Moreover, the
analysis of NRPS with unknown activity has an overall average
of 12 kb and 41% GC content, encoding thioesterase, AMP
binding and condensation starter.DiscussionThe genus Chryseobacterium (chry.se.o.bac.teri.um, Gr. adj.
chryseos, “golden”) [1], deﬁned in 1994 by Vandamme et al.,
comprises six species, including C. indologenes (previously Fla-
vobacterium indologenes), which is the most common clinical
species in this genus [30]. C. indologenes is an opportunistic
pathogen causing nosocomial infections in the presence of an
open wound or indwelling device. C. indologenes infection can
be lethal in immunocompromised patients [2].
We explored the chromosomally encoded determinants that
contribute to the phenotype of resistance of C. indologenes to
β-lactams in blaIND-2 and blaCIA genes. These genes conferred,
respectively, resistance to amino and carboxypenicillins [31],FIG. 4. Modular organization of polyketide synthase in Chryseobacterium indolo
Saccharopolispora erythraea NRRL 2338.
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
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narrow-spectrum cephalosporins and imipenem.
The 289–amino acid blaCIA shared 99% identity with already
reported blaCIA (BAL 40893.1) class A enzymes. The positivity
of the Carba NP phenotypic test conﬁrms the presence of
carbapenemase production due to the presence of the blaIND-2
gene. Flavin monooxygenase is a vivid example, which demon-
strates the enormous adaptability of bacteria: they can freely
utilize their protective armor in a large variety of ecological
compartments in response to yet another challenge, this time
inﬂicted by humans in the form of antibiotic selective pressure
[32]. Some authors suggest that exposure to long-term antibi-
otics for eradicating bacteria in CF disease select the bacteria,
especially multidrug-resistant bacteria, as we have reported
elsewhere [33].
C. indologenes shows a characteristic yellowish pigmentation
on agar plates, caused by the production of carotenoids, as
reported for other Chryseobacterium species [1]. Carotenoid
biosynthesis is an ancient process; it is quite plausible that these
pigments originally evolved to play a role in membrane stabili-
zation and ultraviolet tolerance [34] and to function as pro-
tectors against photodamage, as they are able to quenchgenes MARS15, C. indologenes NBRC 14944, C. indologenes STRB126 and
iology and Infectious Diseases, NMNI, 12, 35–42
nses/by-nc-nd/4.0/).
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C. indologenes could play a virulence protective role by allowing
a given microbe to evade host immune killing or by provoking
inﬂammatory damage to cells and tissues [35]. The danger of
pigmented pathogens might be further heightened in patients
with particular immunodeﬁciencies such as we describe. Ca-
rotenoids occur sporadically in nonphotosynthetic bacteria and
eukaryotes [36].
Urease is well recognized as an important virulence factor
and could be involved in nitrogen assimilation [37], aiding
bacterial survival in the acid microenvironment of the inﬂamed
human respiratory tract in patients with chronic obstructive
pulmonary disease.
Moreover, the presence of an intact phage in our clinical
strain but its absence in the other strain may confer a
competitive advantage in chronic lung infection [38].
The ability to produce a secondary metabolite remains silent
or inactive under normal laboratory conditions [39]. Therefore,
it is difﬁcult to study the mechanisms and signaling pathways
behind secondary metabolism activation. Differing from the
essential role of a primary metabolite, a secondary metabolite
serves instead to increase the ﬁtness of the producing organism
or to decrease the ﬁtness of surrounding organisms [40], as is
the case of Paenibacillus thiaminolyticus OSY-SE [41], or to adapt
to the harsh environment of the inﬂamed lung.ConclusionHere we decipher for the ﬁrst time by WGS analysis the
resistome of C. indologenes, an emerging multidrug-resistant
bacterium, from the sputum of a CF patient in France. At the
same time, by means of these studies we can map the presence
of a biosynthetic gene that could be encoded for novel natural
bioactive products. Moreover, thanks to analysis with WGS, we
can improve knowledge of multidrug-resistant bacteria and
elaborate the mechanism of adaptation of this environmental
bacterium to harsh conditions of chronic human infection, such
as in CF.
Genome sequence accession number
The genome of C. indologenes MARS15 has been submitted to
the European Bioinformatics Institute database under bio-
project ID PRJEB12508 with accession number
FCNN01000001–FCNN01000381.Conﬂict of InterestNone declared.© 2016 The Authors. Published by Elsevier Ltd on behal
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